[ Price : $8.95]
Three Sidley attorneys suggest ways drug companies can take advantage of the flexibility in FDAs guidance on using alternative too...[ Price : $8.95]
FDA issues an alert after becoming aware that Abbott issued a letter to customers recommending updated instructions when removing ...[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at Wichita, KS-based Fagron Compounding Services.[ Price : $8.95]
FDA approves Biocon Biologics biosimilars for Amgens Prolia and Xgeva.[ Price : $8.95]
FDA issues a draft guidance revising and updating a 2013 guidance on safety labeling changes when new safety information becomes a...[ Price : $8.95]
The House Energy and Commerce Committee unanimously approves legislation to reauthorize FDAs Rare Pediatric Disease Priority Revie...[ Price : $8.95]
FDA publishes a guidance to help sponsors with clinical trials for drugs to treat symptomatic nonerosive gastroesophageal reflux d...[ Price : $8.95]
Johnson & Johnson reports favorable data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies that showed its experimental psoriasis dr...